This page is specifically intended to support patients who have been prescribed LUCENTIS by a UK healthcare provider. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.

 

   

Below are some resources designed for people who have been prescribed LUCENTIS®. These provide information on various ophthalmological conditions, as well as about LUCENTIS treatment. Please select the resources that are relevant to the eye condition for which LUCENTIS has been prescribed.

 

Lucentis parent/guardian booklet (ROP) thumbnail

LUCENTIS parent/guardian booklet (ROP)

A leaflet on retinopathy of prematurity (ROP) for parents of infants who are receiving treatment with LUCENTIS.

Download

Thumbnail image of understanding DMO booklet

Understanding diabetic macular oedema (DMO) & what to expect from your LUCENTIS treatment

A leaflet for patients who have been prescribed LUCENTIS as a treatment for visual impairment due to DMO.

Download

Thumbnail image of Lucentis patient information DMO/PDR booklet

LUCENTIS patient information booklet (DMO/PDR)

A booklet containing important information for people who have been prescribed LUCENTIS for the treatment of visual impairment due to diabetic macular oedema (DMO).

View  Audio  

 

Thumbnail image of Lucentis (wAMD) patient information booklet

LUCENTIS patient information booklet (wAMD)

A booklet containing important information for people who have been prescribed LUCENTIS for the treatment of wet age-related macular degeneration (wAMD).

View  Audio  

Thumbnail image of Lucentis (RVO) patient information booklet

LUCENTIS patient information booklet (RVO)

A booklet containing important information for people who have been prescribed LUCENTIS for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO).

View  Audio  

Thumbnail image of Lucentis patient information (CNV) booklet

LUCENTIS patient information booklet (CNV)

A booklet containing important information for people who have been prescribed LUCENTIS for the treatment of visual impairment due to choroidal neovascularisation (CNV).

View  Audio  

 

See What's Next logo

See What’s Next is an educational website for people with wet age-related macular degeneration (wet AMD) and their caregivers. Click the logo above to find more information on topics such as disease management, adapting to daily life and caregiver support.

You can find out more about retina support and information on retinal diseases on the websites of the following organisations. The below links will take you to the Macular Society or the Royal National Institute of Blind People, which are non-Novartis websites.

 

 Image of Macular Society logo
 Image of RNIB logo
 

AMD, age-related macular degeneration; CNV, choroidal neovascularisation; DMO, diabetic macular oedema; PDR, proliferative diabetic retinopathy; ROP, retinopathy of prematurity; RVO, retinal vein occlusion; VEGF, vascular endothelial growth factor.

UK | May 2021 | 109441
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.